📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Defining disease modification in myelofibrosis in the era of targeted therapy. (2022)

First Author: Pemmaraju N

Attributed to: The Oxford Single Cell Biology Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cncr.34205

PubMed Identifier: 35499819

Publication URI: http://europepmc.org/abstract/MED/35499819

Type: Journal Article/Review

Volume: 128

Parent Publication: Cancer

Issue: 13

ISSN: 0008-543X